25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

AFFY (Affymax) Stock Analysis
Buy, Hold or Sell?

Let's analyze Affymax together

I guess you are interested in Affymax Inc.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Affymax’s Financial Insights
  • 📈 Technical Analysis (TA) – Affymax’s Price Targets

I'm going to help you getting a better view of Affymax Inc.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Affymax Inc.

I send you an email if I find something interesting about Affymax Inc..

1. Quick Overview

1.1. Quick analysis of Affymax (30 sec.)










1.2. What can you expect buying and holding a share of Affymax? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$-0.04
Expected worth in 1 year
$-1.07
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
$-1.04
Return On Investment
-129,487.5%

For what price can you sell your share?

Current Price per Share
$0.00
Expected price per share
$0.0001 - $0.0008
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Affymax (5 min.)




Live pricePrice per Share (EOD)
$0.00
Intrinsic Value Per Share
$-18.02 - $-14.01
Total Value Per Share
$-18.05 - $-14.05

2.2. Growth of Affymax (5 min.)




Is Affymax growing?

Current yearPrevious yearGrowGrow %
How rich?-$1.4m$8.2m-$9.7m-679.9%

How much money is Affymax making?

Current yearPrevious yearGrowGrow %
Making money-$14.4m-$93.4m$78.9m547.6%
Net Profit Margin-1,053.6%-99.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Affymax (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Affymax?

Welcome investor! Affymax's management wants to use your money to grow the business. In return you get a share of Affymax.

First you should know what it really means to hold a share of Affymax. And how you can make/lose money.

Speculation

The Price per Share of Affymax is $0.0008. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Affymax.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Affymax, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.04. Based on the TTM, the Book Value Change Per Share is $-0.26 per quarter. Based on the YOY, the Book Value Change Per Share is $-1.81 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Affymax.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.38-48,092.7%-0.38-48,092.7%-2.49-311,455.6%-1.50-188,053.0%-1.39-173,251.7%-1.31-163,926.6%
Usd Book Value Change Per Share-0.26-32,371.9%-0.26-32,371.9%-1.81-225,779.6%-0.66-82,216.1%-0.06-6,943.2%0.00-476.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.26-32,371.9%-0.26-32,371.9%-1.81-225,779.6%-0.66-82,216.1%-0.06-6,943.2%0.00-476.1%
Usd Price Per Share0.78-0.78-18.99-8.79-11.55-12.42-
Price to Earnings Ratio-2.03--2.03--7.62--4.56--8.70--9.37-
Price-to-Total Gains Ratio-3.01--3.01--10.51-19.43-23.70-11.68-
Price to Book Ratio-20.48--20.48-85.97-22.92-17.21-14.86-
Price-to-Total Gains Ratio-3.01--3.01--10.51-19.43-23.70-11.68-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0008
Number of shares1250000
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.26-0.06
Usd Total Gains Per Share-0.26-0.06
Gains per Quarter (1250000 shares)-323,718.80-69,431.66
Gains per Year (1250000 shares)-1,294,875.18-277,726.65
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-1294875-12948850-277727-277737
20-2589750-25897600-555453-555464
30-3884626-38846350-833180-833191
40-5179501-51795100-1110907-1110918
50-6474376-64743850-1388633-1388645
60-7769251-77692600-1666360-1666372
70-9064126-90641350-1944087-1944099
80-10359001-103590100-2221813-2221826
90-11653877-116538850-2499540-2499553
100-12948752-129487600-2777267-2777280

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.010.00.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%4.06.00.040.0%4.06.00.040.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.010.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%4.06.00.040.0%4.06.00.040.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Affymax Inc. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.259-0.2590%-1.806+597%-0.658+154%-0.056-79%-0.004-99%
Book Value Per Share---0.038-0.0380%0.221-117%0.737-105%1.186-103%0.618-106%
Current Ratio--0.7130.7130%1.035-31%2.397-70%2.142-67%5.838-88%
Debt To Asset Ratio--1.1921.1920%0.930+28%0.828+44%0.723+65%1.273-6%
Debt To Equity Ratio----0%13.276-100%4.614-100%3.363-100%3.730-100%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--25968278.00025968278.0000%679982999.000-96%336422279.333-92%448061015.400-94%597898602.000-96%
Eps---0.385-0.3850%-2.492+548%-1.504+291%-1.386+260%-1.311+241%
Ev To Ebitda Ratio---1.817-1.8170%-7.561+316%-4.838+166%-10.301+467%-12.351+580%
Ev To Sales Ratio--18.96918.9690%7.205+163%10.843+75%8.659+119%22.896-17%
Free Cash Flow Per Share---1.796-1.7960%-1.100-39%-1.617-10%-1.672-7%-1.086-40%
Free Cash Flow To Equity Per Share---2.056-2.0560%-0.484-76%-1.010-51%-0.605-71%-0.051-98%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---14.012----------
Intrinsic Value_10Y_min---18.016----------
Intrinsic Value_1Y_max---1.574----------
Intrinsic Value_1Y_min---1.723----------
Intrinsic Value_3Y_max---4.600----------
Intrinsic Value_3Y_min---5.279----------
Intrinsic Value_5Y_max---7.470----------
Intrinsic Value_5Y_min---8.920----------
Market Cap29992.080-97400%29242278.00029242278.0000%711936999.000-96%329662946.000-91%433160615.400-93%465477081.600-94%
Net Profit Margin---10.536-10.5360%-0.990-91%-4.271-59%-2.721-74%-60.166+471%
Operating Margin---10.969-10.9690%-0.975-91%-4.409-60%-2.806-74%-62.681+471%
Operating Ratio--28.77928.7790%1.975+1357%11.540+149%7.987+260%126.031-77%
Pb Ratio-0.021+100%-20.478-20.4780%85.972-124%22.918-189%17.211-219%14.862-238%
Pe Ratio-0.002+100%-2.027-2.0270%-7.621+276%-4.562+125%-8.704+329%-9.374+362%
Price Per Share0.001-97400%0.7800.7800%18.990-96%8.793-91%11.554-93%12.416-94%
Price To Free Cash Flow Ratio0.000+100%-0.434-0.4340%-17.262+3875%-7.027+1518%-7.486+1624%-4.106+846%
Price To Total Gains Ratio-0.003+100%-3.012-3.0120%-10.514+249%19.434-115%23.701-113%11.679-126%
Quick Ratio--0.6310.6310%1.071-41%3.090-80%2.726-77%8.716-93%
Return On Assets---1.938-1.9380%-0.790-59%-1.081-44%-0.743-62%-0.592-69%
Return On Equity----0%-11.2800%-4.0290%-2.6850%-2.3980%
Total Gains Per Share---0.259-0.2590%-1.806+597%-0.658+154%-0.056-79%-0.004-99%
Usd Book Value---1428000.000-1428000.0000%8281000.000-117%27616666.667-105%44460400.000-103%23151700.000-106%
Usd Book Value Change Per Share---0.259-0.2590%-1.806+597%-0.658+154%-0.056-79%-0.004-99%
Usd Book Value Per Share---0.038-0.0380%0.221-117%0.737-105%1.186-103%0.618-106%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--25968278.00025968278.0000%679982999.000-96%336422279.333-92%448061015.400-94%597898602.000-96%
Usd Eps---0.385-0.3850%-2.492+548%-1.504+291%-1.386+260%-1.311+241%
Usd Free Cash Flow---67339000.000-67339000.0000%-41242000.000-39%-60604000.000-10%-62683800.000-7%-40702100.000-40%
Usd Free Cash Flow Per Share---1.796-1.7960%-1.100-39%-1.617-10%-1.672-7%-1.086-40%
Usd Free Cash Flow To Equity Per Share---2.056-2.0560%-0.484-76%-1.010-51%-0.605-71%-0.051-98%
Usd Market Cap29992.080-97400%29242278.00029242278.0000%711936999.000-96%329662946.000-91%433160615.400-93%465477081.600-94%
Usd Price Per Share0.001-97400%0.7800.7800%18.990-96%8.793-91%11.554-93%12.416-94%
Usd Profit---14424000.000-14424000.0000%-93412000.000+548%-56401000.000+291%-51961800.000+260%-49165000.000+241%
Usd Revenue--1369000.0001369000.0000%94370000.000-99%47819666.667-97%74175800.000-98%51001700.000-97%
Usd Total Gains Per Share---0.259-0.2590%-1.806+597%-0.658+154%-0.056-79%-0.004-99%
 EOD+2 -6MRQTTM+0 -0YOY+13 -233Y+12 -245Y+8 -2810Y+11 -25

3.3 Fundamental Score

Let's check the fundamental score of Affymax Inc. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.002
Price to Book Ratio (EOD)Between0-1-0.021
Net Profit Margin (MRQ)Greater than0-10.536
Operating Margin (MRQ)Greater than0-10.969
Quick Ratio (MRQ)Greater than10.631
Current Ratio (MRQ)Greater than10.713
Debt to Asset Ratio (MRQ)Less than11.192
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-1.938
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of Affymax Inc. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5053.962
Ma 20Greater thanMa 500.001
Ma 50Greater thanMa 1000.001
Ma 100Greater thanMa 2000.001
OpenGreater thanClose0.001
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Affymax Inc.

Affymax, Inc. does not have significant operations. Previously, it was developing drugs to enhance the treatment of serious and often life-threatening conditions in the United States. The company was founded in 2001 and is based in New York, New York.

Fundamental data was last updated by Penke on 2025-06-26 20:28:06.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Affymax earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Affymax to the Biotechnology industry mean.
  • A Net Profit Margin of -1,053.6% means that $-10.54 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Affymax Inc.:

  • The MRQ is -1,053.6%. The company is making a huge loss. -2
  • The TTM is -1,053.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-1,053.6%TTM-1,053.6%0.0%
TTM-1,053.6%YOY-99.0%-954.6%
TTM-1,053.6%5Y-272.1%-781.6%
5Y-272.1%10Y-6,016.6%+5,744.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,053.6%-93.6%-960.0%
TTM-1,053.6%-140.9%-912.7%
YOY-99.0%-197.6%+98.6%
3Y-427.1%-248.5%-178.6%
5Y-272.1%-343.4%+71.3%
10Y-6,016.6%-496.2%-5,520.4%
4.3.1.2. Return on Assets

Shows how efficient Affymax is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Affymax to the Biotechnology industry mean.
  • -193.8% Return on Assets means that Affymax generated $-1.94 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Affymax Inc.:

  • The MRQ is -193.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -193.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-193.8%TTM-193.8%0.0%
TTM-193.8%YOY-79.0%-114.8%
TTM-193.8%5Y-74.3%-119.5%
5Y-74.3%10Y-59.2%-15.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-193.8%-11.6%-182.2%
TTM-193.8%-11.6%-182.2%
YOY-79.0%-11.4%-67.6%
3Y-108.1%-11.8%-96.3%
5Y-74.3%-12.0%-62.3%
10Y-59.2%-13.7%-45.5%
4.3.1.3. Return on Equity

Shows how efficient Affymax is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Affymax to the Biotechnology industry mean.
  • 0.0% Return on Equity means Affymax generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Affymax Inc.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-1,128.0%+1,128.0%
TTM-5Y-268.5%+268.5%
5Y-268.5%10Y-239.8%-28.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--13.5%+13.5%
TTM--14.9%+14.9%
YOY-1,128.0%-14.6%-1,113.4%
3Y-402.9%-16.8%-386.1%
5Y-268.5%-17.5%-251.0%
10Y-239.8%-19.9%-219.9%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Affymax Inc..

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Affymax is operating .

  • Measures how much profit Affymax makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Affymax to the Biotechnology industry mean.
  • An Operating Margin of -1,096.9% means the company generated $-10.97  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Affymax Inc.:

  • The MRQ is -1,096.9%. The company is operating very inefficient. -2
  • The TTM is -1,096.9%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-1,096.9%TTM-1,096.9%0.0%
TTM-1,096.9%YOY-97.5%-999.4%
TTM-1,096.9%5Y-280.6%-816.4%
5Y-280.6%10Y-6,268.1%+5,987.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,096.9%-232.5%-864.4%
TTM-1,096.9%-250.5%-846.4%
YOY-97.5%-209.2%+111.7%
3Y-440.9%-234.1%-206.8%
5Y-280.6%-346.1%+65.5%
10Y-6,268.1%-477.5%-5,790.6%
4.3.2.2. Operating Ratio

Measures how efficient Affymax is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 28.78 means that the operating costs are $28.78 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Affymax Inc.:

  • The MRQ is 28.779. The company is inefficient in keeping operating costs low. -1
  • The TTM is 28.779. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ28.779TTM28.7790.000
TTM28.779YOY1.975+26.803
TTM28.7795Y7.987+20.791
5Y7.98710Y126.031-118.044
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ28.7792.111+26.668
TTM28.7792.694+26.085
YOY1.9753.096-1.121
3Y11.5403.652+7.888
5Y7.9874.745+3.242
10Y126.0316.614+119.417
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Affymax Inc..

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Affymax is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.71 means the company has $0.71 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Affymax Inc.:

  • The MRQ is 0.713. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.713. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.713TTM0.7130.000
TTM0.713YOY1.035-0.322
TTM0.7135Y2.142-1.429
5Y2.14210Y5.838-3.696
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7133.661-2.948
TTM0.7133.846-3.133
YOY1.0354.140-3.105
3Y2.3974.688-2.291
5Y2.1425.746-3.604
10Y5.8386.147-0.309
4.4.3.2. Quick Ratio

Measures if Affymax is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Affymax to the Biotechnology industry mean.
  • A Quick Ratio of 0.63 means the company can pay off $0.63 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Affymax Inc.:

  • The MRQ is 0.631. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.631. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.631TTM0.6310.000
TTM0.631YOY1.071-0.440
TTM0.6315Y2.726-2.095
5Y2.72610Y8.716-5.990
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6312.848-2.217
TTM0.6313.169-2.538
YOY1.0713.786-2.715
3Y3.0904.311-1.221
5Y2.7265.703-2.977
10Y8.7166.368+2.348
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Affymax Inc..

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Affymax assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Affymax to Biotechnology industry mean.
  • A Debt to Asset Ratio of 1.19 means that Affymax assets are financed with 119.2% credit (debt) and the remaining percentage (100% - 119.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Affymax Inc.:

  • The MRQ is 1.192. The company is just not able to pay all its debts by selling its assets. -1
  • The TTM is 1.192. The company is just not able to pay all its debts by selling its assets. -1
Trends
Current periodCompared to+/- 
MRQ1.192TTM1.1920.000
TTM1.192YOY0.930+0.262
TTM1.1925Y0.723+0.469
5Y0.72310Y1.273-0.550
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1920.329+0.863
TTM1.1920.349+0.843
YOY0.9300.331+0.599
3Y0.8280.340+0.488
5Y0.7230.349+0.374
10Y1.2730.379+0.894
4.5.4.2. Debt to Equity Ratio

Measures if Affymax is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Affymax to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Affymax Inc.:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY13.276-13.276
TTM-5Y3.363-3.363
5Y3.36310Y3.730-0.368
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.379-0.379
TTM-0.437-0.437
YOY13.2760.414+12.862
3Y4.6140.450+4.164
5Y3.3630.464+2.899
10Y3.7300.515+3.215
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Affymax generates.

  • Above 15 is considered overpriced but always compare Affymax to the Biotechnology industry mean.
  • A PE ratio of -2.03 means the investor is paying $-2.03 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Affymax Inc.:

  • The EOD is -0.002. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.027. Based on the earnings, the company is expensive. -2
  • The TTM is -2.027. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.002MRQ-2.027+2.025
MRQ-2.027TTM-2.0270.000
TTM-2.027YOY-7.621+5.594
TTM-2.0275Y-8.704+6.677
5Y-8.70410Y-9.374+0.670
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.002-2.356+2.354
MRQ-2.027-2.077+0.050
TTM-2.027-2.574+0.547
YOY-7.621-3.760-3.861
3Y-4.562-3.773-0.789
5Y-8.704-6.193-2.511
10Y-9.374-6.876-2.498
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Affymax Inc.:

  • The EOD is 0.000. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.434. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.434. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD0.000MRQ-0.434+0.434
MRQ-0.434TTM-0.4340.000
TTM-0.434YOY-17.262+16.828
TTM-0.4345Y-7.486+7.052
5Y-7.48610Y-4.106-3.380
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.000-3.246+3.246
MRQ-0.434-2.705+2.271
TTM-0.434-3.704+3.270
YOY-17.262-4.402-12.860
3Y-7.027-5.070-1.957
5Y-7.486-8.477+0.991
10Y-4.106-9.305+5.199
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Affymax is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -20.48 means the investor is paying $-20.48 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Affymax Inc.:

  • The EOD is -0.021. Based on the equity, the company is expensive. -2
  • The MRQ is -20.478. Based on the equity, the company is expensive. -2
  • The TTM is -20.478. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.021MRQ-20.478+20.457
MRQ-20.478TTM-20.4780.000
TTM-20.478YOY85.972-106.450
TTM-20.4785Y17.211-37.689
5Y17.21110Y14.862+2.349
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.0212.038-2.059
MRQ-20.4781.843-22.321
TTM-20.4782.125-22.603
YOY85.9722.442+83.530
3Y22.9182.492+20.426
5Y17.2113.652+13.559
10Y14.8624.311+10.551
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2009-12-312010-12-312011-12-312012-12-312013-12-31
Total Stockholder Equity 66,9055,64272,5473,45075,997-67,7168,281-9,709-1,428
Net Working Capital  57,018-5,09351,92535,92987,854-84,4193,435-5,984-2,549



6.2. Latest Balance Sheet

Balance Sheet of 2013-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets7,443
Total Liabilities8,871
Total Stockholder Equity-1,428
 As reported
Total Liabilities 8,871
Total Stockholder Equity+ -1,428
Total Assets = 7,443

Assets

Total Assets7,443
Total Current Assets6,322
Long-term Assets1,121
Total Current Assets
Cash And Cash Equivalents 5,597
Other Current Assets 725
Total Current Assets  (as reported)6,322
Total Current Assets  (calculated)6,322
+/-0
Long-term Assets
Other Assets 1,121
Long-term Assets  (as reported)1,121
Long-term Assets  (calculated)1,121
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities8,871
Long-term Liabilities0
Total Stockholder Equity-1,428
Total Current Liabilities
Accounts payable 101
Other Current Liabilities 8,770
Total Current Liabilities  (as reported)8,871
Total Current Liabilities  (calculated)8,871
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock37
Retained Earnings -558,137
Other Stockholders Equity 556,672
Total Stockholder Equity (as reported)-1,428
Total Stockholder Equity (calculated)-1,428
+/-0
Other
Cash and Short Term Investments 5,597
Common Stock Shares Outstanding 37,448
Liabilities and Stockholders Equity 7,443
Net Debt -5,597
Net Tangible Assets -1,428
Net Working Capital -2,549



6.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-31
> Total Assets 
64,761
36,907
0
27,728
60,960
249,988
225,792
167,720
211,510
131,387
118,995
118,217
7,443
7,443118,217118,995131,387211,510167,720225,792249,98860,96027,728036,90764,761
   > Total Current Assets 
0
0
0
25,340
58,615
240,624
194,812
127,081
190,739
99,542
107,620
102,510
6,322
6,322102,510107,62099,542190,739127,081194,812240,62458,61525,340000
       Cash And Cash Equivalents 
0
0
0
1,657
14,399
147,541
108,215
24,046
125,296
63,499
54,339
68,265
5,597
5,59768,26554,33963,499125,29624,046108,215147,54114,3991,657000
       Short-term Investments 
0
0
0
23,063
43,494
76,751
60,122
70,673
35,292
33,582
44,165
9,717
0
09,71744,16533,58235,29270,67360,12276,75143,49423,063000
       Net Receivables 
0
0
0
0
0
10,191
15,331
24,353
20,004
0
6,937
18,365
0
018,3656,937020,00424,35315,33110,19100000
       Other Current Assets 
0
0
0
620
722
4,576
11,144
8,009
10,147
2,461
2,179
6,163
725
7256,1632,1792,46110,1478,00911,1444,576722620000
   > Long-term Assets 
0
0
0
2,388
2,345
9,364
30,980
40,639
20,771
31,845
11,375
15,707
1,121
1,12115,70711,37531,84520,77140,63930,9809,3642,3452,388000
       Property Plant Equipment 
0
0
0
1,053
1,110
2,014
4,470
6,952
5,469
3,982
3,012
2,981
0
02,9813,0123,9825,4696,9524,4702,0141,1101,053000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
19,876
0
2,323
0
02,323019,876000000000
       Other Assets 
0
0
0
1,335
1,235
1,217
10,855
10,742
7,324
7,987
8,362
10,403
1,121
1,12110,4038,3627,9877,32410,74210,8551,2171,2351,335000
> Total Liabilities 
0
0
0
114,890
174,651
133,089
141,607
158,736
144,605
58,840
42,998
109,936
8,871
8,871109,93642,99858,840144,605158,736141,607133,089174,651114,890000
   > Total Current Liabilities 
0
0
0
2,146
5,377
11,972
55,698
93,351
133,721
47,617
19,766
99,075
8,871
8,87199,07519,76647,617133,72193,35155,69811,9725,3772,146000
       Short-term Debt 
0
0
0
0
223
293
133
14
9,192
0
0
8,844
0
08,844009,192141332932230000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
8,844
0
08,84400000000000
       Accounts payable 
0
0
0
806
3,336
9,113
9,348
614
464
321
941
6,591
101
1016,5919413214646149,3489,1133,336806000
       Other Current Liabilities 
0
0
0
1,340
1,818
2,566
6,729
37,793
52,093
28,799
18,825
83,640
8,770
8,77083,64018,82528,79952,09337,7936,7292,5661,8181,340000
   > Long-term Liabilities 
0
0
0
112,744
169,274
121,117
85,909
65,385
10,884
11,223
23,232
10,861
0
010,86123,23211,22310,88465,38585,909121,117169,274112,744000
       Other Liabilities 
0
0
0
348
180
120,977
85,901
65,385
10,884
11,223
22,695
10,861
0
010,86122,69511,22310,88465,38585,901120,977180348000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
5,174
0
0
005,1740000000000
> Total Stockholder Equity
-9,172
-37,281
0
-87,162
-113,691
116,899
84,185
8,984
66,905
72,547
75,997
8,281
-1,428
-1,4288,28175,99772,54766,9058,98484,185116,899-113,691-87,1620-37,281-9,172
   Common Stock
0
0
0
723
0
15
15
15
24
25
36
37
37
37373625241515150723000
   Retained Earnings -558,137-543,713-450,301-388,934-374,859-298,328-211,818-168,749-120,461-87,8850-38,290-10,244
   Capital Surplus 0000000000000
   Treasury Stock0000000000000
   Other Stockholders Equity 
1,072
1,009
0
0
276,029
285,771
296,035
306,828
441,795
461,425
526,244
551,959
556,672
556,672551,959526,244461,425441,795306,828296,035285,771276,029001,0091,072



6.4. Balance Sheets

Currency in USD. All numbers in thousands.




6.5. Cash Flows

Currency in USD. All numbers in thousands.




6.6. Income Statements

Currency in USD. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2013-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue1,369
Cost of Revenue-12
Gross Profit1,3571,357
 
Operating Income (+$)
Gross Profit1,357
Operating Expense-39,386
Operating Income-15,046-38,029
 
Operating Expense (+$)
Research Development11,857
Selling General Administrative27,529
Selling And Marketing Expenses0
Operating Expense39,38639,386
 
Net Interest Income (+$)
Interest Income0
Interest Expense-1,565
Other Finance Cost-1,565
Net Interest Income0
 
Pretax Income (+$)
Operating Income-15,046
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-16,582-13,510
EBIT - interestExpense = -16,582
-16,582
-12,859
Interest Expense1,565
Earnings Before Interest and Taxes (EBIT)-15,017-15,017
Earnings Before Interest and Taxes (EBITDA)-14,295
 
After tax Income (+$)
Income Before Tax-16,582
Tax Provision-0
Net Income From Continuing Ops-14,424-16,582
Net Income-14,424
Net Income Applicable To Common Shares-14,424
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring20,480
Other Operating Expenses39,386
Total Other Income/Expenses Net-1,5360
 

Technical Analysis of Affymax
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Affymax. The general trend of Affymax is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Affymax's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Affymax Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Affymax Inc..

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 0.0008 < 0.0008 < 0.0008.

The bearish price targets are: 0.0001 > 0.0001 > 0.0001.

Know someone who trades $AFFY? Share this with them.👇

Affymax Inc. Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Affymax Inc.. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Affymax Inc. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Affymax Inc.. The current macd is 0.000016.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Affymax price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Affymax. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Affymax price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Affymax Inc. Daily Moving Average Convergence/Divergence (MACD) ChartAffymax Inc. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Affymax Inc.. The current adx is 32.80.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Affymax shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Affymax Inc. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Affymax Inc.. The current sar is 0.00085278.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Affymax Inc. Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Affymax Inc.. The current rsi is 53.96. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Affymax Inc. Daily Relative Strength Index (RSI) ChartAffymax Inc. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Affymax Inc.. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Affymax price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Affymax Inc. Daily Stochastic Oscillator ChartAffymax Inc. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Affymax Inc.. The current cci is 35.09.

Affymax Inc. Daily Commodity Channel Index (CCI) ChartAffymax Inc. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Affymax Inc.. The current cmo is 12.48.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Affymax Inc. Daily Chande Momentum Oscillator (CMO) ChartAffymax Inc. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Affymax Inc.. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Affymax Inc. Daily Williams %R ChartAffymax Inc. Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Affymax Inc..

Affymax Inc. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Affymax Inc.. The current atr is 0.000049.

Affymax Inc. Daily Average True Range (ATR) ChartAffymax Inc. Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Affymax Inc.. The current obv is -2,151.

Affymax Inc. Daily On-Balance Volume (OBV) ChartAffymax Inc. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Affymax Inc.. The current mfi is 58.82.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Affymax Inc. Daily Money Flow Index (MFI) ChartAffymax Inc. Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Affymax Inc..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-03-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-03-10MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-04-21MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-22STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-05-15MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-16WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-05-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-10RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-06-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-13WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-16MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-06-17STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Affymax Inc. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Affymax Inc. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5053.962
Ma 20Greater thanMa 500.001
Ma 50Greater thanMa 1000.001
Ma 100Greater thanMa 2000.001
OpenGreater thanClose0.001
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Affymax with someone you think should read this too:
  • Are you bullish or bearish on Affymax? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Affymax? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Affymax Inc.

I send you an email if I find something interesting about Affymax Inc..


Comments

How you think about this?

Leave a comment

Stay informed about Affymax Inc..

Receive notifications about Affymax Inc. in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.